Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids

Video

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
WATCH: Experts react to the FDA approval of sepiapterin to treat PKU
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Related Content
FDA approves first RNA-targeted therapy for hereditary angioedema | Image credit: Contemporary Pediatrics.

FDA approves first RNA-targeted therapy for hereditary angioedema

Morgan Ebert, Managing Editor
August 25th 2025
Article
Centanafadine shows efficacy and tolerability for pediatric ADHD in phase 3 trial | Image Credit: © H_Ko - stock.adobe.com.

Centanafadine shows efficacy and tolerability for pediatric ADHD in phase 3 trial

Morgan Ebert, Managing Editor
August 25th 2025
Article
FDA issues CRL for vatiquinone to treat Friedreich's ataxia | Image credit: Contemporary Pediatrics

FDA issues CRL for vatiquinone to treat Friedreich ataxia

Joshua Fitch, Senior Editor
August 25th 2025
Article
Richard Auchus, MD, on how crinecerfont is changing CAH treatment

Richard Auchus, MD, on how crinecerfont is changing CAH treatment

Richard Auchus, MD, PhD
August 25th 2025
Article
FDA approves first generic iron sucrose injection for iron deficiency anemia in CKD | Image credit Contemporary Pediatrics

FDA approves first generic iron sucrose injection for iron deficiency anemia in CKD

Morgan Ebert, Managing Editor
August 25th 2025
Article
FDA approves brensocatib to treat adolescents with non-cystic fibrosis bronchiectasis | Image credit: Contemporary Pediatrics

FDA approves brensocatib to treat adolescents with non–cystic fibrosis bronchiectasis

Joshua Fitch, Senior Editor
August 25th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.